Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titers
Hannes Vietzen(Medical University of Vienna), Elisabeth Puchhammer-Stöckl(Medical University of Vienna), Barbara Kornek(Medical University of Vienna), Paulus Rommer(Medical University of Vienna), Gabriel Bsteh(Medical University of Vienna), S. Berger(Department of Virology), Markus Ponleitner(Medical University of Vienna), Kevin Rostásy(Witten/Herdecke University), Thomas Berger(Medical University of Vienna), Markus Reindl(Innsbruck Medical University), Eva‐Maria Wendel(Olgahospital), Marianne Graninger(Medical University of Vienna), Laura M. Kühner(Department of Virology), Charlotte Pistorius(Austrian Red Cross), Henrieke Saucke(Witten/Herdecke University), Markus Breu(Medical University of Vienna), Franziska Kauth(Witten/Herdecke University), Christof Jungbauer(Paracelsus Medical University)
Cited by 16
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Toll-like Receptor 4 Polymorphisms and Atherogenesis
|New England Journal of Medicine|2002|1k
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
|Journal of Neurology Neurosurgery & Psychiatry|2016|297